CRNT
Overvalued by 173.6% based on the discounted cash flow analysis.
Market cap | $230.63 Million |
---|---|
Enterprise Value | $234.99 Million |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $0.07 |
Beta | 0.86 |
Outstanding Shares | 85,418,321 |
Avg 30 Day Volume | 463,161 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 37.08 |
---|---|
PEG | -40.31 |
Price to Sales | 0.69 |
Price to Book Ratio | 2.76 |
Enterprise Value to Revenue | 0.68 |
Enterprise Value to EBIT | 10.12 |
Enterprise Value to Net Income | 37 |
Total Debt to Enterprise | 0.14 |
Debt to Equity | 0.24 |
No data
No data